Skip to Main Content

Paper Details

Postmarket Safety Outcomes for New Molecular Entity (NME) Drugs Approved by the Food and Drug Administration Between 2002 and 2014.
Clin Pharmacol Ther
24
2018
Author NameAffiliation
Diane Marie St GeorgeUniversity of Maryland School of Medicine
Gerald J Dal PanCenter for Drug Evaluation and Research
  • 1 - 2

Datasets

Release 1.2